Finance

Lists
Why is ELOX down 9.49%?
Dive Deeper
ELOX:NASDAQ
Eloxx Pharmaceuticals Inc
$13.74
-9.49%
(-1.44) 1D
Oct 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELOX...
Open
$15.02
High
$15.29
Low
$13.21
Mkt. cap
55.46M
Avg. vol.
27.31K
Volume
31.31K
52-wk high
$23.40
52-wk low
$8.20
Beta
3.68
Shares outstanding
4.04M
No. of employees
10
Open
$15.02
High
$15.29
Low
$13.21
Mkt. cap
55.46M
Avg. vol.
27.31K
Volume
31.31K
52-wk high
$23.40
52-wk low
$8.20
Beta
3.68
Shares outstanding
4.04M
No. of employees
10
News stories
From web sources and news partners
About Eloxx Pharmaceuticals Inc
CEO-
Employees10
Founded1999
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeloxxpharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to ELOX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELOX in the last 3 months.
Highest
Current $13.74
$43.00 (+212.95%)
Average
$38.25 (+178.38%)
Lowest
$32.00 (+132.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Schwartz
Leerink Partners
Buy
Initiated
$32.00
+132.9%
09/18/2026
Vamil Divan
Guggenheim
Buy
Reiterated
$43.00
+213%
08/23/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$38.00
+176.6%
08/20/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$40.00
+191.1%
08/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
510.00K
898.00K
1.66M
2.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
712.00K
684.00K
2.14M
1.61M
Operating expense
1.22M
1.58M
3.80M
4.45M
Total operating expenses
1.22M
1.58M
3.80M
4.45M
Operating income
-1.22M
-1.58M
-3.80M
-4.45M
Other non operating income
-9.00K
-4.00K
-9.00K
-85.00K
EBT including unusual items
-1.71M
-1.89M
-3.75M
-4.50M
EBT excluding unusual items
-1.71M
-1.89M
-3.81M
-4.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.71M
-1.89M
-3.75M
-4.50M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
5.00K
3.00K
23.00K
41.00K
Interest expense
-483.00K
-308.00K
-29.00K
-8.00K
Net interest expenses
-478.00K
-305.00K
-6.00K
33.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.21M
-1.57M
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps